Influence of osteopontin short hairpin RNA on the proliferation and invasion of human renal cancer cells

Journal of Huazhong University of Science and Technology - Medical Science

Volumn 30, Issue 1, 2010, Pages 61-68

  Liu, Hao ^a   Chen, Anmin ^a   Guo, Fengjing ^a   Yuan, Lin ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Human renal cancer cells; Osteopontin; RNA interference; Short hairpin RNA

Indexed keywords

GELATINASE A; GELATINASE B; MESSENGER RNA; MMP2 PROTEIN, HUMAN; MMP9 PROTEIN, HUMAN; OSTEOPONTIN; SMALL INTERFERING RNA; SPP1 PROTEIN, HUMAN;

ARTICLE; CANCER INVASION; CELL PROLIFERATION; GENE THERAPY; GENETIC TRANSFECTION; GENETICS; HUMAN; KIDNEY TUMOR; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

CELL LINE, TUMOR; CELL PROLIFERATION; GENETIC THERAPY; HUMANS; KIDNEY NEOPLASMS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; NEOPLASM INVASIVENESS; OSTEOPONTIN; RNA, MESSENGER; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 77149179757     PISSN: 16720733     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11596-011-0111-7     Document Type: Article

References (32)

1. S.R. Rittling A.F. Chambers 2004 Role of oesteopontin in tumor progression Br J Cancer 90 10 1877 1881 10.1038/sj.bjc.6601839 1:CAS:528:DC%2BD2cXjvVals7g%3D 15138464 (Pubitemid 38746324)
2. P.Y. Wai P.C. Kuo 2004 The role of osteopontin in tumor metastasis J Surg Res 121 2 228 241 10.1016/j.jss.2004.03.028 1:CAS:528:DC%2BD2cXovVyru7c%3D 15501463 (Pubitemid 39387464)
3. P.S. Rudland A. Platt-Higgins M. El-Tanani, et al. 2002 Prognostic significance of the metastasis-associated protein osteopontin in human breast cancer Cancer Res 62 12 3417 3427 1:CAS:528:DC%2BD38XkslWqsb0%3D 12067984
4. Y. Shimada G. Watanabe J. Kawamura, et al. 2005 Clinical significance of osteopontin in esophageal squamous cell carcinoma: comparison with common tumor markers Oncology 68 2-3 285 292 10.1159/000086961 1:CAS:528:DC%2BD2MXntFSms7o%3D 16015046 (Pubitemid 41158988)
5. G. Castellano G. Malaponte M.C. Mazzarino, et al. 2008 Activation of the osteopontin/matrix metalloproteinase-9 pathway correlates with prostate cancer progression Clin Cancer Res 14 22 7470 7480 10.1158/1078-0432.CCR-08-0870 1:CAS:528:DC%2BD1cXhtlylurzK 19010864
6. S. Philip G.C. Kundu 2003 Osteopontin induces nuclear factor kappa B-mediated promatrix metalloproteinase-2 activation through I kappa B alpha /IKK signaling pathways, and curcumin (diferulolylmethane) down-regulates these pathways J Biol Chem 278 16 14 487 14 497 10.1074/jbc.M207309200 1:CAS:528:DC%2BD3sXjtVShtr8%3D (Pubitemid 36800002)
7. H. Rangaswami A. Bulbule G.C. Kundu 2004 Nuclear factor-inducing kinase plays a crucial role in osteopontin-induced MAPK/I kappa B alpha kinase-dependent nuclear factor kappa B-mediated promatrix metalloproteinase-9 activation J Biol Chem 279 37 38 921 38 935 10.1074/jbc.M404674200 1:CAS:528:DC%2BD2cXnt1yjsLw%3D (Pubitemid 39296053)
8. B. Desai T. Ma J. Zhu, et al. 2009 Characterization of the expression of variant and standard CD44 in prostate cancer cells: identification of the possible molecular mechanism of CD44/MMP9 complex formation on the cell surface J Cell Biochem 108 1 272 284 10.1002/jcb.22248 1:CAS:528:DC%2BD1MXhtVGju7rO 19582779
9. A. Lipton A. Colombo-Berra R.M. Bukowski, et al. 2004 Skeletal complications in patients with bone metastases from renal cell carcinoma and therapeutic benefits of zoledronic acid Clin Cancer Res 10 18Pt2 6397S 6403S 10.1158/1078-0432.CCR-040030 1:CAS:528:DC%2BD2cXnvVOjtr0%3D 15448038 (Pubitemid 39287498)
10. K.L. Weber M. Doucet J.E. Price 2003 Renal cell carcinoma bone metastasis: epidermal growth factor receptor targeting Clin Orthop Relat Res 415 Suppl S86 S94 10.1097/01.blo.0000093050.96273.35 14600596
11. K. Weber M. Doucet S. Kominsky 2007 Renal cell carcinoma bone metastasis-elucidating the molecular targets Cancer Metastasis Rev 26 3-4 691 704 10.1007/s10555-007-9090-y 17768599 (Pubitemid 350115120)
12. W.T. Butler 1989 The nature and significance of osteopontin Connect Tissue Res 23 2-3 123 136 10.3109/03008208909002412 1:STN:280: DyaK3c3gtVequg%3D%3D 2698313
13. D.T. Denhardt X. Guo 1993 Osteopontin: a protein with diverse functions FASEB J 7 15 1475 1482 1:CAS:528:DyaK2cXkvVaiug%3D%3D 8262332
14. C.W. Prince 1989 Secondary structure predictions for rat osteopontin Connect Tissue Res 21 1-4 15 20 10.3109/03008208909049991 1:STN:280: DyaK3c7gslCgsg%3D%3D 2605939
15. A.B. Tuck D.M. Arsenault F.P. O'Malley, et al. 1999 Osteopontin induces increased invasiveness and plasminogen activator expression of human mammary epithelial cells Oncogene 18 29 4237 4236 10.1038/sj.onc.1202799 1:CAS:528:DyaK1MXlt1OlsLs%3D 10435636 (Pubitemid 29377854)
16. A.C. Khodavirdi Z. Song S. Yang, et al. 2006 Increased expression of osteopontin contributes to the progression of prostate cancer Cancer Res 66 2 883 888 10.1158/0008-5472.CAN-05-2816 1:CAS:528:DC%2BD28XlsFOqsw%3D%3D 16424021 (Pubitemid 43165954)
17. C.J. Piyathilake A.R. Frost U. Manne, et al. 2002 Differential expression of growth factors in squamous cell carcinoma and precancerous lesions of the lung Clin Cancer Res 8 3 734 744 1:CAS:528:DC%2BD38XislOqtLo%3D 11895903
18. Y. Wu D.T. Denhardt S.R. Rittling 2000 Osteopontin is required for full expression of the transformed phenotype by the ras oncogene Br J Cancer 83 2 156 163 10.1054/bjoc.2000.1200 1:CAS:528:DC%2BD3cXltl2muro%3D 10901364
19. A.R. Naqvi M.N. Islan N.R. Choudhury, et al. 2009 The fascinating world of RNA interference Int J Biol Sci 5 2 97 117 1:CAS:528:DC%2BD1MXnsl2rur4%3D 19173032
20. T.R. Brummelkamp R. Bernards R. Agami 2002 A system for stable expression of short interfering RNAs in mammalian cells Science 296 5567 550 553 10.1126/science.1068999 1:CAS:528:DC%2BD38XjtFCjtrk%3D 11910072 (Pubitemid 34408678)
21. R. Wadhwa S.C. Kaul M. Miyagishi, et al. 2004 Know-how of RNA interference and its applications in research and therapy Mutat Res 567 1 71 84 10.1016/j.mrrev.2004.06.002 1:CAS:528:DC%2BD2cXntlels78%3D 15341903 (Pubitemid 39162994)
22. C.P. Paul P.D. Good I. Winer, et al. 2002 Effective expression of small interfering RNA in human cells Nat Biotechnol 20 5 505 508 10.1038/nbt0502-505 1:CAS:528:DC%2BD38Xjt1Kntrg%3D 11981566 (Pubitemid 34495939)
23. A.B. Tuck C. Hota S.M. Wilson, et al. 2003 Osteopontin induced migration of human mammary epithelial cells involves activation of EGF receptor and multiple signal transduction pathways Oncogene 22 8 1198 1205 10.1038/sj.onc.1206209 1:CAS:528:DC%2BD3sXhsVyqtr4%3D 12606946 (Pubitemid 36363383)
24. A.B. Tuck B.E. Elliott C. Hota, et al. 2000 Chambers, Osteopontin-induced, integrin-dependent migration of human mammary epithelial cells involves activation of the hepatocyte growth factor receptor (Met) J Cell Biochem 78 3 465 475 10.1002/1097-4644(20000901)78:3<465::AID-JCB11>3.0. CO;2-C 1:CAS:528:DC%2BD3cXltlShtLs%3D 10861844 (Pubitemid 30491074)
25. Y.H. Lin C.J. Huang J.R. Chao, et al. 2000 Coupling of osteopontin and its cell surface receptor CD44 to the cell survival response elicited by interleukin-3 or granulocyte-macrophage colony-stimulating factor Mol Cell Biol 20 8 2734 2742 10.1128/MCB.20.8.2734-2742.2000 1:CAS:528:DC%2BD3cXit1ymu7o%3D 10733576 (Pubitemid 30183492)
26. B. Zhu K. Suzuki H.A. Goldberg, et al. 2004 Osteopontin modulates CD44-dependent chemotaxis of peritoneal macrophages through G-protein-coupled receptors: evidence of a role for an intracellular form of osteopontin J Cell Physiol 198 1 155 167 10.1002/jcp.10394 1:CAS:528:DC%2BD3sXpsVCmtb0%3D 14584055 (Pubitemid 38120976)
27. R. Das G.H. Mahabeleshwar G.C. Kundu, et al. 2003 Osteopontin stimulates cell motility and nuclear factor kappaB-mediated secretion of urokinase type plasminogen activator through phosphatidylinositol 3-kinase/Akt signaling pathways in breast cancer cells J Biol Chem 278 3 28 593 28 606 10.1074/jbc.M303445200 1:CAS:528:DC%2BD3sXlsl2ntb0%3D (Pubitemid 36935765)
28. R. Katso K. Okkenhaug K. Ahmadi, et al. 2001 Cellular function of phosphoinositide 3-kinases: implications for development, homeostasis, and cancer Annu Rev Cell Dev Biol 17 615 675 10.1146/annurev.cellbio.17.1.615 1:CAS:528:DC%2BD3MXos1OmsbY%3D 11687500 (Pubitemid 33096187)
29. B. Samolov B. Steen S. Seregard, et al. 2005 Delayed inflammation- associated corneal neovascularization in MMP-2-deficient mice Exp Eye Res 80 2 159 166 10.1016/j.exer.2004.08.023 1:CAS:528:DC%2BD2MXms1Gjtw%3D%3D 15670794
30. A. Scorilas A. Karameris N. Amogiannaki, et al. 2001 Overexpression of matrix-metalloproteinase-9 in human breast cancer: a potential favorable indicator in node-negative patients Br J Cancer 84 11 1488 1496 10.1054/bjoc.2001.1810 1:STN:280:DC%2BD3MzhtFGmtg%3D%3D 11384099 (Pubitemid 32579341)
31. E. Hrabec M. Strek D. Nowak, et al. 2001 Elevated level of circulating matrix metalloproteinase-9 in patients with lung cancer Respir Med 95 1 1 4 10.1053/rmed.2000.0923 1:STN:280:DC%2BD3M7jsVeqsA%3D%3D 11207010 (Pubitemid 32621978)
32. Y. Sakamoto K. Mafune M. Mori, et al. 2000 Overexpression of MMP-9 correlates with growth of small hepatocellular carcinoma Int J Oncol 17 2 237 243 1:CAS:528:DC%2BD3cXls1KltbY%3D 10891530